BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 18438905)

  • 1. Validity, reliability, and feasibility of durometer measurements of scleroderma skin disease in a multicenter treatment trial.
    Merkel PA; Silliman NP; Denton CP; Furst DE; Khanna D; Emery P; Hsu VM; Streisand JB; Polisson RP; Akesson A; Coppock J; van den Hoogen F; Herrick A; Mayes MD; Veale D; Seibold JR; Black CM; Korn JH; ;
    Arthritis Rheum; 2008 May; 59(5):699-705. PubMed ID: 18438905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Durometry for the assessment of skin disease in systemic sclerosis.
    Kissin EY; Schiller AM; Gelbard RB; Anderson JJ; Falanga V; Simms RW; Korn JH; Merkel PA
    Arthritis Rheum; 2006 Aug; 55(4):603-9. PubMed ID: 16874783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A stretchable hardness sensor for the assessment of skin disease in systemic sclerosis.
    Wang X; Liu M; Ye T; Huang J; Xu X; Li M; Zhao X; Lu H; Yang J
    RMD Open; 2023 Nov; 9(4):. PubMed ID: 37996124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The correlation between durometer score and modified Rodnan skin score in systemic sclerosis.
    Moon KW; Song R; Kim JH; Lee EY; Lee EB; Song YW
    Rheumatol Int; 2012 Aug; 32(8):2465-70. PubMed ID: 21769489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Scleroderma Clinical Trials Consortium training recommendations on modified Rodnan skin score assessment in scleroderma.
    Low AHL; Ng SA; Berrocal V; Brennan B; Chan G; Ng SC; Khanna D
    Int J Rheum Dis; 2019 Jun; 22(6):1036-1040. PubMed ID: 30838791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Durometry as an alternative tool to the modified Rodnan's skin score in the assessment of diffuse systemic sclerosis patients: a cross-sectional study.
    de Oliveira MFC; Leopoldo VC; Pereira KRC; de Moraes DA; Dias JBE; Gonçalves MS; Ramalho LNZ; Dos Santos BN; de Oliveira MC; Silveira RCCP
    Adv Rheumatol; 2020 Sep; 60(1):48. PubMed ID: 32958068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inter- and Intra-Observer Reliability of Modified Rodnan Skin Score Assessment in Thai Systemic Sclerosis Patients: A Validation for Multicenter Scleroderma Cohort Study.
    Foocharoen C; Thinkhamrop B; Mahakkanukrauh A; Suwannaroj S; Netwijitpan S; Sripavatakul K; Chuealee W; Boottam B; Towiwat P; Seubmee P; Daungkum K; Kongpan D; Mangkala J; Nanagara R
    J Med Assoc Thai; 2015 Nov; 98(11):1082-8. PubMed ID: 26817178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Minimal Clinically Important Differences for the Modified Rodnan Skin Score: Results from the Scleroderma Lung Studies (SLS-I and SLS-II).
    Khanna D; Clements PJ; Volkmann ER; Wilhalme H; Tseng CH; Furst DE; Roth MD; Distler O; Tashkin DP
    Arthritis Res Ther; 2019 Jan; 21(1):23. PubMed ID: 30651141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Skin involvement in systemic sclerosis.
    Czirják L; Foeldvari I; Müller-Ladner U
    Rheumatology (Oxford); 2008 Oct; 47 Suppl 5():v44-5. PubMed ID: 18784142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patterns and predictors of change in outcome measures in clinical trials in scleroderma: an individual patient meta-analysis of 629 subjects with diffuse cutaneous systemic sclerosis.
    Merkel PA; Silliman NP; Clements PJ; Denton CP; Furst DE; Mayes MD; Pope JE; Polisson RP; Streisand JB; Seibold JR;
    Arthritis Rheum; 2012 Oct; 64(10):3420-9. PubMed ID: 22328195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The health assessment questionnaire (HAQ) is strongly predictive of good outcome in early diffuse scleroderma: results from an analysis of two randomized controlled trials in early diffuse scleroderma.
    Sultan N; Pope JE; Clements PJ;
    Rheumatology (Oxford); 2004 Apr; 43(4):472-8. PubMed ID: 14679295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-throughput quantitative histology in systemic sclerosis skin disease using computer vision.
    Correia C; Mawe S; Lofgren S; Marangoni RG; Lee J; Saber R; Aren K; Cheng M; Teaw S; Hoffmann A; Goldberg I; Cowper SE; Khatri P; Hinchcliff M; Mahoney JM
    Arthritis Res Ther; 2020 Mar; 22(1):48. PubMed ID: 32171325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measuring disease activity and functional status in patients with scleroderma and Raynaud's phenomenon.
    Merkel PA; Herlyn K; Martin RW; Anderson JJ; Mayes MD; Bell P; Korn JH; Simms RW; Csuka ME; Medsger TA; Rothfield NF; Ellman MH; Collier DH; Weinstein A; Furst DE; Jiménez SA; White B; Seibold JR; Wigley FM;
    Arthritis Rheum; 2002 Sep; 46(9):2410-20. PubMed ID: 12355489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variability of skin scores and clinical measurements in scleroderma.
    Pope JE; Baron M; Bellamy N; Campbell J; Carette S; Chalmers I; Dales P; Hanly J; Kaminska EA; Lee P
    J Rheumatol; 1995 Jul; 22(7):1271-6. PubMed ID: 7562757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of a durometer to assess skin hardness.
    Falanga V; Bucalo B
    J Am Acad Dermatol; 1993 Jul; 29(1):47-51. PubMed ID: 8315077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Course of the modified Rodnan skin thickness score in systemic sclerosis clinical trials: analysis of three large multicenter, double-blind, randomized controlled trials.
    Amjadi S; Maranian P; Furst DE; Clements PJ; Wong WK; Postlethwaite AE; Khanna PP; Khanna D;
    Arthritis Rheum; 2009 Aug; 60(8):2490-8. PubMed ID: 19644851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Self-assessment of skin tightness severity by scleroderma patients.
    Daungkum K; Foocharoen C; Mahakkanukrauh A; Suwannaroj S; Thinkhamrop B; Nanagara R
    Int J Rheum Dis; 2016 Oct; 19(10):989-995. PubMed ID: 27126197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlates and responsiveness to change of measures of skin and musculoskeletal disease in early diffuse systemic sclerosis.
    Wiese AB; Berrocal VJ; Furst DE; Seibold JR; Merkel PA; Mayes MD; Khanna D
    Arthritis Care Res (Hoboken); 2014 Nov; 66(11):1731-9. PubMed ID: 24692361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-frequency ultrasound of the skin in systemic sclerosis: an exploratory study to examine correlation with disease activity and to define the minimally detectable difference.
    Li H; Furst DE; Jin H; Sun C; Wang X; Yang L; He J; Wang Y; Liu A
    Arthritis Res Ther; 2018 Aug; 20(1):181. PubMed ID: 30115105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Establishment and partial validation of a patient skin self-assessment questionnaire in systemic sclerosis.
    Nagy Z; Bálint Z; Farkas H; Radics J; Kumánovics G; Minier T; Varjú C; Czirják L
    Rheumatology (Oxford); 2009 Mar; 48(3):309-14. PubMed ID: 19181657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.